EMA Authorised: RotaTeq (rotavirus serotype G1;rotavirus serotype G2;rotavirus serotype G3;rotavirus serotype G4;rotavirus serotype P1) — Merck Sharp & Dohme B.V.

View source ↗

Summary

The EMA authorised RotaTeq (pentavalent rotavirus vaccine) by Merck Sharp & Dohme B.V. for immunization against rotavirus infections. This marks the marketing a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis
• Rotavirus Infections

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Status: Authorised. Therapeutic area: Immunization;Rotavirus Infections. MAH: Merck Sharp & Dohme B.V.. Decision date: 11/12/2025